59° Congresso Internazionale Multisala SCIVAC
microflora in a group of dogs with naturally occurring EPI;50 however, a study completed in dogs with experimentallyinduced EPI revealed that clinical signs improved with pancreatic enzyme supplementation alone.51 Administration of tylosin (20-40 mg/kg bid for 2-3 weeks), oral oxytetracycline (10-20 mg/kg bid for 2-3 weeks), or oral metronidazole (10-20 mg/kg bid for 2-3 weeks) may improve overall response to therapy.
545
17.
18.
19.
20.
Glucocorticoid therapy Failure to respond to the abovementioned therapeutic measures warrants consideration of concurrent lymphocytic-plasmacytic gastroenteritis, which if confirmed via gastrointestinal biopsy, may resolve with concurrent prednisone therapy.
21.
22. 23. 24.
References 1.
2. 3.
4.
5.
6.
7.
8.
9. 10. 11. 12.
13.
14.
15.
16.
Guilford WG: Nutritional management of gastrointestinal diseases. In Guilford WG, Center SA, Strombeck DR, Williams DA and Meyer DJ, eds.: Strombeck’s Small Animal Gastroenterology. Third Ed. Philadelphia: WB Saunders, 1996, pp 889-910. Guilford WG: Personal communication, Davis, CA, 1999. Foster L.A, Hoskinson J.J, Goggin J.M, and Butine M.D. Gastric emptying of diets varying in micronutrient composition in cats. Proceedings, 1998 Purina Nutrition Forum, p 61). Lin HC, Doty JE, Reedy TJ, et al: Inhibition of gastric emptying by sodium oleate depends on length of intestine exposed by nutrient. Am J Physiol 259:G1031-1036, 1990. Meyer JH, Elashoff JD, Domeck M, et al. Control of canine gastric emptying of fat by lipolytic products. Am J Physiol 266:G1017-1035, 1994. Hofmann AF, Poley JR: Role of bile acid malabsorption in pathogenesis of diarrhea and steatorrhea in patients with ileal resection: I. Response to cholestyramine or replacement of dietary long chain triglyceride by medium chain triglyceride. Gastroenterology 62:918934, 1972. Cummings JH, Wiggins HS, Jenkins DJA, et al: Influence of diets high and low in animal fat on bowel habit, gastrointestinal transit time, fecal microflora, bile acid, and fat excretion. J Clin Invest 61:953-963, 1978. Guilford WG, Jones BR, Markwell PJ, Arthur DG, Collett MG and Harte JG. Food sensitivity in cats with chronic idiopathic gastrointestinal problems. JVIM 15: 7-13, 2001. Nelson RW, Stookey LJ, Kazacos E. Nutritional management of idiopathic chronic colitis in the dog. JVIM 2:133-137, 1988. Nelson RW, Dimperio ME, Long GG. Lymphocytic-plasmacytic colitis in the cat. JAVMA 184: 1133-1135, 1984. Paterson S. Food hypersensitivity in 20 dogs with gastrointestinal signs. JSAP 36:529-534, 1995. Guilford WG: Idiopathic inflammatory bowel diseases. In Guilford WG, Center SA, Strombeck DR, Williams DA and Meyer DJ, eds.: Strombeck’s Small Animal Gastroenterology. Third Ed. Philadelphia: WB Saunders, 1996, pp 451-486. Mansfield JC, Giaffer MH, Holdsworth CD: Controlled diet of oligopeptide versus amino acid diet in treatment of active Crohn’s disease. Gut 36:60-66, 1995. Casellas F, Agaude S, Soriano B, et al: Intestinal permeability to 99mTc-diethylenetriaminopentaacetic acid in inflammatory bowel disease. Am J Gastroenterol 81:767-770, 1986. Mayberry JF, Rhodes J, Heatley RV: Infections which cause ileocolic disease in animals: Are they relevant to Crohn’s disease? Gastroenterology 78:1080-1084, 1980. Belsheim MR, Darwish RZ, Watson WC, et al: Bacterial L-form isolation from inflammatory bowel disease patients. Gastroenterology 85:364-369, 1983.
25.
26.
27.
28. 29.
30.
31.
32.
33.
34.
35.
36. 37. 38.
39.
40.
41.
42.
Giaffer MH, Cann P, Holdsworth CD: Long-term effects of elemental and exclusion diets for Crohn’s disease. Aliment Pharmacol Ther 5:115-125, 1988. Batt RM, McLean L, Riley JE: Response of the jejunal mucosa of dogs with aerobic and anaerobic bacterial overgrowth to antibiotic therapy. Gut 29:473-482, 1988. Sartor RB: Microbial factors in the pathogenesis of Crohn’s disease, ulcerative colitis and experimental intestinal inflammation, in Kirsner JB, Shorter RG (eds): Inflammatory bowel disease. Baltimore, MD, Williams & Wilkins, 1995, pp 96-124. Leib MS, Hiler LA, Thatcher C, et al: Plasmacytic lymphocytic colitis in the dog. Sem Vet Med Surg 4:241-246, 1989. Simpson JW, Maskell IE, Markwell PJ: Use of a restricted antigen diet in the management of idiopathic canine colitis. J Small Anim Prac 35:233-238, 1994. Willard MD: Dietary therapy in large intestinal diseases. Proc 6th ACVIM 713, 1988. Marks SL. Management of canine inflammatory bowel disease. Comp Cont Ed 20: 317-332, 1998. Sparkes AH, Papasouliotis K, Sunvold G et al. Bacterial flora in the duodenum of healthy cats and effect of dietary supplementation with fructooligosaccharides. AJVR 59: 431-435, 1998. Sparkes AH, Papasouliotis K, Sunvold G et al. Effect of dietary supplementation with fructooligosaccharides on fecal flora of healthy cats. AJVR 59: 436-440, 1998. Willard MD, Simpson RB, Delles EK et al. Effects of dietary supplementation of fructooligosaccharides on small intestinal bacterial overgrowth in dogs. AJVR 55:654-659, 1994. Leib MS. Treatment of chronic idiopathic large bowel diarrhea in dogs with a highly digestible diet and soluble fiber: A retrospective review of 37 cases. JVIM 14: 27-32, 2000. Hawthorne AB, Edwards T, Filopowicz B et al. Fish oil modifies neutrophil (PMN) function in ulcerative colitis. Gut A738, 1989. Scheurlen M, Dais W, Steinhilber D et al. Effects of long-term application of fish oil on patients with Crohn’s disease. Scand J Gastroenterol Suppl 158; 100-101, 1989. Hawthorne AB, Daneshmend TK, Hawkey CJ et al. Treatment of ulcerative colitis with fish oil supplementation: A prospective 12month randomized controlled trial. Gut 33: 922-928, 1992. Girelli D, Olivieri O, Stanzial AM et al. Factors affecting the thibarbituric acid test as index of red blood cell susceptibility to lipid peroxidation: a mulitvariate analysis. Clin Chim Acta 227: 45-57, 1994. Vaughn DM, Reinhart GA, Swaim SF, et al. Evaluation of effects of dietary n-6 to n-3 fatty acid ratios on leukotriene B synthesis in dog skin and neutrophils. Vet Derm 5: 163, 1994. Reinhart GA, Vaughn DM. Dietary fatty acid ratios and tissue fatty acid content. Proc 13th ACVIM Forum, Lake Buena Vista, FL, 1995: 466-469. Ohlsson K, Ganrot PO, Laurell CB: In vivo interaction between trypsin and some plasma proteins in relation to tolerance to intravenous infusion of trypsin in dogs. Acta Chir Scand 137:113-121, 1971. Leese T, Holliday M, Heath D, et al: Multicentre clinical trial of low volume fresh frozen plasma therapy in acute pancreatitis. Br J Surg 74:907-911, 1987. Williams DA. Personal communication, Florida, 1989. Akol K, Washabau R, Saunders H, et al. Acute Pancreatitis in Cats with hepatic Lipidosis. J Vet Intern Med 7:205-209, 1993. Hill R, Van Winkle T. Acute Necrotizing Pancreatitis and Acute Suppurative Pancreatitis in the Cat: a retrospective study of 40 cases (1976-1989). J Vet Intern Med 7:25-33, 1993. Williams DA: The pancreas. In Guilford WG, Center SA, Strombeck DR, Williams DA and Meyer DJ, eds.: Strombeck’s Small Animal Gastroenterology. Third Ed. Philadelphia: WB Saunders, 1996, p 381. Westermarck E, Junttila J, Wiberg M. The role of low dietary fat in the treatment of dogs with exocrine pancreatic insufficiency. Am J Vet Res 56:600-605, 1995. Suzuki A, Mizumoto A, rerknimitr R, et al. Effect of bacterial or porcine lipase with low- or high-fat diets on nutrient absorption in pancreatic-insufficient dogs. Gastroenterology 116:431-437, 1999. Isaksson G, Lundquist I, Akesson B, et al. Effects of pectin and wheat